149 related articles for article (PubMed ID: 24670698)
1. Impact of the Xpert(®) MTB/RIF molecular test on the late diagnosis of pulmonary tuberculosis.
Ramirez HL; García-Clemente MM; Alvarez-Álvarez C; Palacio-Gutierrez JJ; Pando-Sandoval A; Gagatek S; Arias-Guillén M; Quezada-Loaiza CA; Casan-Clará P
Int J Tuberc Lung Dis; 2014 Apr; 18(4):435-7. PubMed ID: 24670698
[TBL] [Abstract][Full Text] [Related]
2. Added value of molecular assay Xpert MTB/RIF compared to sputum smear microscopy to assess the risk of tuberculosis transmission in a low-prevalence country.
Opota O; Senn L; Prod'hom G; Mazza-Stalder J; Tissot F; Greub G; Jaton K
Clin Microbiol Infect; 2016 Jul; 22(7):613-9. PubMed ID: 27139592
[TBL] [Abstract][Full Text] [Related]
3. Xpert MTB/RIF assay can be used on archived gastric aspirate and induced sputum samples for sensitive diagnosis of paediatric tuberculosis.
Singh S; Singh A; Prajapati S; Kabra SK; Lodha R; Mukherjee A; Singh V; Hesseling AC; Grewal HM;
BMC Microbiol; 2015 Sep; 15():191. PubMed ID: 26420261
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of Xpert® MTB/RIF on bronchoscopy specimens in patients with suspected pulmonary tuberculosis.
Lee HY; Seong MW; Park SS; Hwang SS; Lee J; Park YS; Lee CH; Lee SM; Yoo CG; Kim YW; Han SK; Yim JJ
Int J Tuberc Lung Dis; 2013 Jul; 17(7):917-21. PubMed ID: 23621953
[TBL] [Abstract][Full Text] [Related]
5. Burden of tuberculosis in intensive care units in Cape Town, South Africa, and assessment of the accuracy and effect on patient outcomes of the Xpert MTB/RIF test on tracheal aspirate samples for diagnosis of pulmonary tuberculosis: a prospective burden of disease study with a nested randomised controlled trial.
Calligaro GL; Theron G; Khalfey H; Peter J; Meldau R; Matinyenya B; Davids M; Smith L; Pooran A; Lesosky M; Esmail A; Miller MG; Piercy J; Michell L; Dawson R; Raine RI; Joubert I; Dheda K
Lancet Respir Med; 2015 Aug; 3(8):621-30. PubMed ID: 26208996
[TBL] [Abstract][Full Text] [Related]
6. Do we need transbronchial lung biopsy if we have bronchoalveolar lavage Xpert® MTB/RIF?
Mok Y; Tan TY; Tay TR; Wong HS; Tiew PY; Kam JW; Siao C
Int J Tuberc Lung Dis; 2016 May; 20(5):619-24. PubMed ID: 27084815
[TBL] [Abstract][Full Text] [Related]
7. Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial.
Theron G; Zijenah L; Chanda D; Clowes P; Rachow A; Lesosky M; Bara W; Mungofa S; Pai M; Hoelscher M; Dowdy D; Pym A; Mwaba P; Mason P; Peter J; Dheda K;
Lancet; 2014 Feb; 383(9915):424-35. PubMed ID: 24176144
[TBL] [Abstract][Full Text] [Related]
8. Reassessment of the positive predictive value and specificity of Xpert MTB/RIF: a diagnostic accuracy study in the context of community-wide screening for tuberculosis.
Ho J; Nguyen PTB; Nguyen TA; Tran KH; Van Nguyen S; Nguyen NV; Nguyen HB; Luu KB; Fox GJ; Marks GB
Lancet Infect Dis; 2016 Sep; 16(9):1045-1051. PubMed ID: 27289387
[TBL] [Abstract][Full Text] [Related]
9. Comparison of molecular and immunological methods for the rapid diagnosis of smear-negative tuberculosis.
Jafari C; Ernst M; Kalsdorf B; Lange C
Int J Tuberc Lung Dis; 2013 Nov; 17(11):1459-65. PubMed ID: 24125451
[TBL] [Abstract][Full Text] [Related]
10. Systematic review: Comparison of Xpert MTB/RIF, LAMP and SAT methods for the diagnosis of pulmonary tuberculosis.
Yan L; Xiao H; Zhang Q
Tuberculosis (Edinb); 2016 Jan; 96():75-86. PubMed ID: 26786658
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the Xpert MTB/RIF assay for diagnosis of tuberculosis with gastric lavage aspirates in children in sub-Saharan Africa: a prospective descriptive study.
Bates M; O'Grady J; Maeurer M; Tembo J; Chilukutu L; Chabala C; Kasonde R; Mulota P; Mzyece J; Chomba M; Mukonda L; Mumba M; Kapata N; Rachow A; Clowes P; Hoelscher M; Mwaba P; Zumla A
Lancet Infect Dis; 2013 Jan; 13(1):36-42. PubMed ID: 23134697
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment.
Friedrich SO; Rachow A; Saathoff E; Singh K; Mangu CD; Dawson R; Phillips PP; Venter A; Bateson A; Boehme CC; Heinrich N; Hunt RD; Boeree MJ; Zumla A; McHugh TD; Gillespie SH; Diacon AH; Hoelscher M;
Lancet Respir Med; 2013 Aug; 1(6):462-70. PubMed ID: 24429244
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Xpert MTB/RIF assay at a tertiary care referral hospital in a setting where tuberculosis and HIV infection are highly endemic.
O'Grady J; Bates M; Chilukutu L; Mzyece J; Cheelo B; Chilufya M; Mukonda L; Mumba M; Tembo J; Chomba M; Kapata N; Maeurer M; Rachow A; Clowes P; Hoelscher M; Mwaba P; Zumla A
Clin Infect Dis; 2012 Nov; 55(9):1171-8. PubMed ID: 22806590
[TBL] [Abstract][Full Text] [Related]
14. [Use of the Xpert
Horo K; N'Guessan R; Koffi MO; Kouamé-N'Takpé N; Koné A; Samaké K; Koffi L; Ahui BJM; Brou-Gode CV; N'Gom A; Kouassi BA; Koffi N; Aka-Danguy E
Rev Mal Respir; 2017 Sep; 34(7):749-757. PubMed ID: 28189438
[TBL] [Abstract][Full Text] [Related]
15. Time delay and associated mortality from negative smear to positive Xpert MTB/RIF test among TB/HIV patients: a retrospective study.
Lisboa M; Fronteira I; Colove E; Nhamonga M; Martins MDRO
BMC Infect Dis; 2019 Jan; 19(1):18. PubMed ID: 30616533
[TBL] [Abstract][Full Text] [Related]
16. Molecular detection of Mycobacterium tuberculosis from sputum transported in PrimeStore(®) from rural settings.
Daum LT; Peters RP; Fourie PB; Jonkman K; Worthy SA; Rodriguez JD; Ismail NA; Omar SV; Fischer GW
Int J Tuberc Lung Dis; 2015 May; 19(5):552-7. PubMed ID: 25868023
[TBL] [Abstract][Full Text] [Related]
17. Patient costs for the diagnosis of tuberculosis in Brazil: comparison of Xpert MTB/RIF and smear microscopy.
da Silva Antunes R; Pinto M; Trajman A
Int J Tuberc Lung Dis; 2014 May; 18(5):547-51. PubMed ID: 24903791
[TBL] [Abstract][Full Text] [Related]
18. Role of Xpert MTB/RIF in differentiating tuberculosis from sarcoidosis in patients with mediastinal lymphadenopathy undergoing EBUS-TBNA: a study of 147 patients.
Dhooria S; Gupta N; Bal A; Sehgal IS; Aggarwal AN; Sethi S; Behera D; Agarwal R
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):258-266. PubMed ID: 27758992
[TBL] [Abstract][Full Text] [Related]
19. The utility of Xpert MTB/RIF performed on bronchial washings obtained in patients with suspected pulmonary tuberculosis in a high prevalence setting.
Barnard DA; Irusen EM; Bruwer JW; Plekker D; Whitelaw AC; Deetlefs JD; Koegelenberg CF
BMC Pulm Med; 2015 Sep; 15():103. PubMed ID: 26377395
[TBL] [Abstract][Full Text] [Related]
20. Successes, challenges and lessons from a novel deployment of Xpert(®) MTB/RIF at a major South African public event [Short Communication].
Page-Shipp L; Stevens W; Clark D; Scott L; Olsen F; Kisbey-Green H; Mametja D; Churchyard G
Int J Tuberc Lung Dis; 2014 Apr; 18(4):438-40. PubMed ID: 24670699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
